optinose uk limited

Dissolved 

optinose uk limited Company Information

Share OPTINOSE UK LIMITED

Company Number

05091128

Shareholders

optinose as

Group Structure

View All

Industry

Research and experimental development on biotechnology

 

Registered Address

10 fleet place, london, EC4M 7RB

optinose uk limited Estimated Valuation

£363.3k

Pomanda estimates the enterprise value of OPTINOSE UK LIMITED at £363.3k based on a Turnover of £402.4k and 0.9x industry multiple (adjusted for size and gross margin).

optinose uk limited Estimated Valuation

£332.1k

Pomanda estimates the enterprise value of OPTINOSE UK LIMITED at £332.1k based on an EBITDA of £92.2k and a 3.6x industry multiple (adjusted for size and gross margin).

optinose uk limited Estimated Valuation

£0

Pomanda estimates the enterprise value of OPTINOSE UK LIMITED at £0 based on Net Assets of £-31k and 1.59x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Optinose Uk Limited Overview

Optinose Uk Limited is a dissolved company that was located in london, EC4M 7RB with a Companies House number of 05091128. It operated in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in April 2004, it's largest shareholder was optinose as with a 100% stake. The last turnover for Optinose Uk Limited was estimated at £402.4k.

View Sample
View Sample
View Sample

Optinose Uk Limited Health Check

Pomanda's financial health check has awarded Optinose Uk Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

2 Strong

positive_score

0 Regular

positive_score

7 Weak

size

Size

annual sales of £402.4k, make it smaller than the average company (£2.8m)

£402.4k - Optinose Uk Limited

£2.8m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -16%, show it is growing at a slower rate (11.8%)

-16% - Optinose Uk Limited

11.8% - Industry AVG

production

Production

with a gross margin of 30.7%, this company has a higher cost of product (52.1%)

30.7% - Optinose Uk Limited

52.1% - Industry AVG

profitability

Profitability

an operating margin of 7% make it more profitable than the average company (-12.7%)

7% - Optinose Uk Limited

-12.7% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (40)

2 - Optinose Uk Limited

40 - Industry AVG

paystructure

Pay Structure

on an average salary of £136.3k, the company has a higher pay structure (£70.4k)

£136.3k - Optinose Uk Limited

£70.4k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £201.2k, this is more efficient (£122.8k)

£201.2k - Optinose Uk Limited

£122.8k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Optinose Uk Limited

- - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Optinose Uk Limited

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Optinose Uk Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (31 weeks)

3 weeks - Optinose Uk Limited

31 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 107.4%, this is a higher level of debt than the average (54.7%)

107.4% - Optinose Uk Limited

54.7% - Industry AVG

OPTINOSE UK LIMITED financials

EXPORTms excel logo

Optinose Uk Limited's latest turnover from December 2020 is £402.4 thousand and the company has net assets of -£31 thousand. According to their latest financial statements, Optinose Uk Limited has 2 employees and maintains cash reserves of £29 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover402,400439,130985,125671,372715,927364,232364,567482,796465,326487,628492,461479,805
Other Income Or Grants
Cost Of Sales278,845312,913803,141465,053491,870212,947221,501318,408303,277325,624188,772
Gross Profit123,555126,217181,984206,319224,057151,285143,066164,388162,049162,004303,689
Admin Expenses95,36691,39980,207199,185166,264140,826160,033172,355171,353174,123312,28510,432
Operating Profit28,18934,818101,7777,13457,79310,459-16,967-7,967-9,304-12,119-8,596-10,432
Interest Payable55,04088,77918,729
Interest Receivable11,76039,554219
Pre-Tax Profit-15,091-14,40783,2677,13457,79310,459-16,967-7,967-9,304-12,119-8,596-10,432
Tax
Profit After Tax-15,091-14,40783,2677,13457,79310,459-16,967-7,967-9,304-12,119-8,596-10,432
Dividends Paid
Retained Profit-15,091-14,40783,2677,13457,79310,459-16,967-7,967-9,304-12,119-8,596-10,432
Employee Costs272,681289,83160,64259,369103,732164,32573,23283,120319,654321,915218,985
Number Of Employees22333345666
EBITDA*92,18598,773152,40110,61957,79310,459-16,967-7,301-8,163-10,978-7,740-10,432

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets136,879200,875264,830162,0486661,8072,948
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets136,879200,875264,830162,0486661,8072,948
Stock & work in progress
Trade Debtors
Group Debtors201,911177,889984,9983,370
Misc Debtors53,34656,94077,317167,758118,7505,1193,9773,63911,8979,6823,7054,017
Cash29,01975,09249,33389,57829,19042,65944,15928,15321,98910,63120,29039,062
misc current assets44
total current assets284,320309,9211,111,648257,336151,31047,77848,13631,79233,88620,31323,99543,079
total assets421,199510,7961,376,478419,384151,31047,77848,13631,79234,55222,12026,94343,079
Bank overdraft
Bank loan
Trade Creditors 1,401103,94751,6104,4083,0183,1144,12931,9764,3703,865
Group/Directors Accounts452,200476,2761,202,175386,476118,398178,109188,097158,216136,564102,441125,621123,634
other short term finances
hp & lease commitments
other current liabilities49,02971,859117,67873,20614,95817,17713,65129,08113,62110,75120,783
total current liabilities452,200526,7061,377,981504,154243,214197,475208,292174,981169,774148,038140,742148,282
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities452,200526,7061,377,981504,154243,214197,475208,292174,981169,774148,038140,742148,282
net assets-31,001-15,910-1,503-84,770-91,904-149,697-160,156-143,189-135,222-125,918-113,799-105,203
total shareholders funds-31,001-15,910-1,503-84,770-91,904-149,697-160,156-143,189-135,222-125,918-113,799-105,203
Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit28,18934,818101,7777,13457,79310,459-16,967-7,967-9,304-12,119-8,596-10,432
Depreciation63,99663,95550,6243,4856661,1411,141856
Amortisation
Tax
Stock
Debtors20,428-827,486894,55745,638117,0011,142338-8,2582,2155,977-3124,017
Creditors-1,401-102,546103,947-51,61047,2021,390-96-1,015-27,84727,6065053,865
Accruals and Deferred Income-49,029-22,830-45,81944,47258,248-2,2193,526-15,43015,4602,870-10,03220,783
Deferred Taxes & Provisions
Cash flow from operations21,327800,883-684,028-42,15746,2428,488-13,875-15,488-22,76513,521-16,95510,199
Investing Activities
capital expenditure-111,651-165,533-3,804
Change in Investments
cash flow from investments-111,651-165,533-3,804
Financing Activities
Bank loans
Group/Directors Accounts-24,076-725,899815,699268,078-59,711-9,98829,88121,65234,123-23,1801,987123,634
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue-94,771
interest-43,280-49,225-18,510
cash flow from financing-67,356-775,124797,189268,078-59,711-9,98829,88121,65234,123-23,1801,98728,863
cash and cash equivalents
cash-46,07325,759-40,24560,388-13,469-1,50016,0066,16411,358-9,659-18,77239,062
overdraft
change in cash-46,07325,759-40,24560,388-13,469-1,50016,0066,16411,358-9,659-18,77239,062

optinose uk limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for optinose uk limited. Get real-time insights into optinose uk limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Optinose Uk Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for optinose uk limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in EC4M area or any other competitors across 12 key performance metrics.

optinose uk limited Ownership

OPTINOSE UK LIMITED group structure

Optinose Uk Limited has no subsidiary companies.

Ultimate parent company

OPTINOSE INC

#0100491

OPTINOSE AS

#0030499

2 parents

OPTINOSE UK LIMITED

05091128

OPTINOSE UK LIMITED Shareholders

optinose as 100%

optinose uk limited directors

Optinose Uk Limited currently has 2 directors. The longest serving directors include Ms Helena Djupesland (Apr 2004) and Mr Michael Berkey (Mar 2020).

officercountryagestartendrole
Ms Helena DjupeslandNorway66 years Apr 2004- Director
Mr Michael Berkey49 years Mar 2020- Director

P&L

December 2020

turnover

402.4k

-8%

operating profit

28.2k

-19%

gross margin

30.8%

+6.83%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2020

net assets

-31k

+0.95%

total assets

421.2k

-0.18%

cash

29k

-0.61%

net assets

Total assets minus all liabilities

optinose uk limited company details

company number

05091128

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

April 2004

age

21

incorporated

UK

ultimate parent company

OPTINOSE INC

accounts

Full Accounts

last accounts submitted

December 2020

previous names

N/A

accountant

-

auditor

SYGMA

address

10 fleet place, london, EC4M 7RB

Bank

-

Legal Advisor

-

optinose uk limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 6 charges/mortgages relating to optinose uk limited. Currently there are 0 open charges and 6 have been satisfied in the past.

optinose uk limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for OPTINOSE UK LIMITED. This can take several minutes, an email will notify you when this has completed.

optinose uk limited Companies House Filings - See Documents

datedescriptionview/download